Cellular therapy following allogeneic stem-cell transplantation.

Item

http://www.wikidata.org/entity/Q36612643

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Cellular therapy following allogeneic stem-cell transplantation.

@ast

Cellular therapy following allogeneic stem-cell transplantation.

@en

type

Item

label

Cellular therapy following allogeneic stem-cell transplantation.

@ast

Cellular therapy following allogeneic stem-cell transplantation.

@en

prefLabel

Cellular therapy following allogeneic stem-cell transplantation.

@ast

Cellular therapy following allogeneic stem-cell transplantation.

@en

P1476

Cellular therapy following allogeneic stem-cell transplantation.

@en

P2093

Alison Rager

http://www.w3.org/2001/XMLSchema#string

David L Porter

http://www.w3.org/2001/XMLSchema#string

P2860

Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma.

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.

Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Tr

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects

P304

409-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2040620711412416

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236106963

http://www.w3.org/2001/XMLSchema#string

P698

23556106

http://www.w3.org/2001/XMLSchema#string

P932

3573422

http://www.w3.org/2001/XMLSchema#string